JOURNAL of
ONCOLOGICAL
SCIENCES

Similar Articles

  • Prognostic Significance of Mucinous Histology in Metastatic Colorectal Cancer Patients Treated with Regorafenib aDivision of Medical Oncology, Marmara University Faculty of Medicine, İstanbul, Türkiye bDepartment of Internal Medicine, Marmara University Faculty of Medicine, İstanbul, Türkiye cClinic of Medical Oncology, Erzurum Training and Research Hospital, Erzurum, Türkiye dDepartment of Pathology, Marmara University Faculty of Medicine, İstanbul, Türkiye DOI: 10.37047/jos.2022-94250 Sayfalar: 53 - 61 896 Viewed.




  • Unresectable Hepatocellular Carcinoma and Prognostic Factors of Sorafenib Treatment: A Real-Life Experience aDivision of Medical Oncology, Ankara Yıldırım Beyazıt University Faculty of Medicine, Ankara, Türkiye bClinic of Medical Oncology, Ankara City Hospital, Ankara, Türkiye cDivision of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Türkiye dDivision of Medical Oncology, Hacettepe University Faculty of Medicine, Ankara, Türkiye eClinic of Medical Oncology, Gülhane Training and Research Hospital, Ankara, Türkiye fClinic of Medical Oncology, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Türkiye DOI: 10.37047/jos.2023-96148 Sayfalar: 72 - 78 741 Viewed.

  • Management of Nasal Lobular Capillary Hemangioma with Sunitinib aDivision of Medical Oncology, Muğla Sıtkı Koçman University Faculty of Medicine, Muğla, Türkiye bDepartment of Internal Medicine, Muğla Sıtkı Koçman University Faculty of Medicine, Muğla, Türkiye cDepartment of Pathology, Muğla Sıtkı Koçman University Faculty of Medicine, Muğla, Türkiye dDepartment of Otorhinolaryngology, Head and Neck Surgery, Muğla Sıtkı Koçman University Faculty of Medicine, Muğla, Türkiye DOI: 10.37047/jos.2023-96095 Sayfalar: 117 - 120 936 Viewed.

  • Lung Carcinoma Developing Afatinib-Associated Skin Reactions aDivision of Medical Oncology, University of Health Sciences Bursa City Hospital, Bursa, Türkiye bClinic of Medical Oncology, Medical Park Karadeniz Hospital, Trabzon, Türkiye cClinic of Internal Medicine, University of Health Sciences Bursa City Hospital, Bursa, Türkiye DOI: 10.37047/jos.2022-92025 Sayfalar: 112 - 116 820 Viewed.


  • Immunotherapy for Lung Cancer aDepartment of Medical Oncology, University of Health Sciences Gülhane Training and Research Hospital, Ankara, Türkiye bDepartment of Pathology, Gazi University School of Medicine, Ankara, Türkiye cDepartment of Medical Oncology, İstanbul University Institute of Oncology, İstanbul, Türkiye dDepartment of Radiology, Ege University Faculty of Medicine, İzmir, Türkiye eDepartment of Medical Oncology, Acıbadem University Faculty of Medicine, İstanbul, Türkiye fDepartment of Medical Oncology, Ankara Yıldırım Beyazıt University Faculty of Medicine, Ankara, Türkiye gDepartment of Radiation Oncology, Ege University Faculty of Medicine, İzmir, Türkiye hDepartment of Chest Diseases, University of Health Sciences, Dr. Suat Seren Chest Diseases and Surgery Training and Research Hospital, İzmir, Türkiye iDepartment of Chest Diseases, University of Health Sciences, Atatürk Chest Diseases and Surgery Training and Research Hospital, Ankara, Türkiye jDivision of Medical Oncology, Koç University Hospital, İstanbul, Türkiye kDepartment of Medical Oncology, Ege University Faculty of Medicine, İzmir, Türkiye DOI: 10.37047/jos.2022-92712 Sayfalar: 97 - 111 833 Viewed.


  • Breast Cancer Metastasis to Nasal Septum aDepartment of Internal Medicine, Muğla Sıtkı Koçman University Faculty of Medicine, Muğla, Türkiye bDepartment of Otorhinolaryngology, Muğla Sıtkı Koçman University Faculty of Medicine, Muğla, Türkiye cDepartment of Pathology, Muğla Sıtkı Koçman University Faculty of Medicine, Muğla, Türkiye dDepartment of Internal Medicine, Division of Medical Oncology, Muğla Sıtkı Koçman University Faculty of Medicine, Muğla, Türkiye DOI: 10.37047/jos.2022-94489 Sayfalar: 181 - 183 925 Viewed.